Guideline authors
The following professional and scientific societies/working groups/organizations/associations have stated their interest in contributing to the compilation of the guideline text and participating in the consensus conference and have sent representatives to the consensus conference (▶ Table 1 
II Guideline Application

Purpose and Objectives
This guideline aims to summarize the current state of knowledge on intrauterine growth restriction (IUGR). It focuses on the definition, etiology, diagnosis and management of care and states the best time to deliver the baby.
Targeted areas of patient care
▪ Inpatient care ▪ Outpatient care
Target patient groups
This guideline is aimed at pregnant patients.
Target user groups/target audience
This guideline is aimed at the following groups: ▪ Gynecologists in private practice (non-hospital based) ▪ Hospital-based gynecologists ▪ Midwives
Adoption of the guideline and period of validity
This guideline is valid from May 1, 2017 through to April 30, 2020 . Because of the contents of this guideline, the above-mentioned period of validity is only an estimate. If important changes to the available evidence should occur, then amendments to the guideline will be published even before the period of validity has expired, after a careful review of the new evidence in accordance with the methodology published by the AWMF.
III Methodology
Basic principles
The methodology used to prepare this guideline is determined by the class assigned to the guideline. The AWMF Guidance Manual (version 1.0) has set out the respective rules and requirements for different classes of guidelines. Guidelines are differentiated into lowest (S1), intermediate (S2) and highest (S3) class. The lowest class is defined as a set of recommendations for action compiled by a non-representative group of experts. In 2004 the S2 class was divided into two subclasses: the systematic evidencebased subclass S2e and the structural consensus-based subclass S2k. The highest S3 class combines both approaches. This guideline is classified as: S2k
Grading of recommendations
While the classification of the quality of the evidence (strength of evidence) serves as an indication of the robustness of the published data and therefore expresses the extent of certainty/uncertainty about the data, the classification of the level of recommendation reflects the results of weighing up the desirable and adverse consequences of alternative approaches. The grading of evidence and the grading of recommendations was not envisaged for S2k class guidelines. Individual recommendations are differentiated by syntax, not by symbols. The syntax chosen for the level of recommendation should be described in the background text (▶ Table 2 ).
Statements
Expert statements included in this guideline which are not recommendations for action but are simple statements of fact are referred to as Statements. It is not possible to provide a level of evidence for these statements.
Achieving consensus and level of consensus
During structured consensus-based decision-making (S2k/S3 level), authorized participants present at a session vote on draft Statements and Recommendations. Discussions during sessions may lead to significant changes in the wording of Statements and Recommendations. The extent of agreement, which depends on the number of participants, is determined at the end of the session (▶ Table 3 ).
Expert consensus
As the name implies, this refers to consensus decisions taken with regard to specific Recommendations/Statements without a previous systematic search of the literature (S2k) or when evidence is lacking (S2e/S3). The term "Expert Consensus" (EC) used here is synonymous with terms such as "Good Clinical Practice" (GCP) and "Clinical Consensus Point" (CCP) used in other guidelines. The level of recommendation is graded as previously described in the Chapter Grading of recommendations but only semantically ("must"/"must not" or "should"/"should not" or "may"/"may not") and without the use of symbols.
▶ Table 2 Grading of recommendations. [5, 6] . The etiology of IUGR is roughly divided into maternal, placental and fetal causes (▶ Table 4 ) [7] . Although the underlying pathophysiological mechanisms may be very different, they often (but not always) lead to the same endpoint: suboptimal uteroplacental perfusion and fetal nutrition. IUGR is therefore associated with high levels of morbidity and mortality.
Description of grade of recommendation Syntax
▶ Table 4 Risk factors for developing intrauterine growth restriction. Common risk factors are highlighted in bold.
Maternal causes
Alcohol abuse [8] Hypertensive disease of pregnancy (pre-eclampsia, gestational hypertension) [9] Drug/nicotine abuse [10, 11] Embryotoxic or fetotoxic medication [12] Maternal age (≥ 35/> 40 years) [13] Maternal weight (high or very low BMI) [14] Low socio-economic status [15, 16] Nulliparity [17] s/p hypertensive disorder in a previous pregnancy s/p IUFD [9] s/p SGA/IUGR [9] Preexisting maternal diseases, which can lead to reduced uteroplacental perfusion or reduced oxygenation of maternal blood, e.g.:
Chronic respiratory disease
Chronic hypertension [18] Chronic renal disease [19] Diabetes mellitus with vascular disease [20] Heart disease, especially cyanotic heart disease [21] Severe anemia Systemic lupus erythematosus and antiphospholipid syndrome [22] Uteroplacental causes Placental abruption [23] Velamentous cord insertion
Placental infarction [24] Disorders of placentation with inadequate trophoblast invasion and increased maternal risk of pre-eclampsia [25] Placental tumors
Fetal causes
Chromosomal abnormalities and syndromic disease [26, 27] Intrauterine infections (particularly cytomegaly, toxoplasmosis, rubella, varicella zoster virus)
Multiple pregnancy [28] Consensus-based Statement 1.S1
Expert consensus Level of consensus +++ SGA = estimated fetal weight or birth weight < 10th percentile IUGR = estimated fetal weight < 10th percentile and/or non-percentile appropriate fetal growth during pregnancy and pathological Doppler of umbilical artery or pathological Doppler of uterine artery or oligohydramnios
Consensus-based Statement 1.S2
Expert consensus Level of consensus +++ Estimated fetal weight or birth weight < 3rd percentile is associated with higher levels of morbidity and mortality.
References: [4] Consensus-based Recommendation 2.E1
Expert consensus Level of consensus +++
Based on their full medical history, all pregnant women must be evaluated for potential risk factors which could predispose to IUGR. Further diagnostic investigations must be offered or carried out if risk factors are present.
References: [5 -7] 3 Diagnostics to Detect Possible IUGR In addition to taking the patientʼs history, a clinical examination and various diagnostic procedures must be carried out to rule out or confirm IUGR. This is an important part of antenatal care as the majority of IUGR are not detected prenatally [29] and undetected IUGR is associated with an 8-fold higher risk of intrauterine fetal death [30] .
Clinical examination
Sonography
3.2.1
Biometry in early pregnancy (crown-rump length)
Fetometry
In addition to estimated fetal weight, fetal abdominal circumference is the most important indicator of IUGR. Fetal head-to-abdomen discrepancy can also be an indication of IUGR. Assessment of estimated fetal weight should also take maternal and paternal characteristics into account [37 -40] . If the estimated fetal weight is below the 10th percentile, further diagnostic investigations must be carried out (including precise sonographic diagnostics, Doppler sonography). 
Management of IUGR
There is still very little evidence about the best antenatal method to monitor a fetus with IUGR [54] . No single monitoring method provides a valid prediction for the outcome of IUGR, which is why a combination of different procedures to monitor growth-retarded fetuses is recommended. References: [55] Consensus-based Recommendation 5.E12
Expert consensus Level of consensus +++
The interval between individual sonography scans to monitor fetal growth should be at least two weeks.
Consensus-based Recommendation 5.E13
Expert consensus Level of consensus +++ Sonographic assessment of amniotic fluid volume must only be interpreted in the context of and together with other monitoring methods.
Consensus-based Recommendation 5.E14
Expert consensus Level of consensus +++
The SDP (single deepest pocket) method should be used to assess amniotic fluid volume.
References: [56 -58] Consensus-based Recommendation 5.E15
Expert consensus Level of consensus +++
The management of IUGR must include Doppler sonography of the umbilical artery as it can reduce perinatal mortality in high-risk pregnancies.
References: [59, 60] The predictive value of Doppler sonography of the uterine arteries in the last third of pregnancy is unclear as no evidence-based data are available. Doppler sonography of other arterial (e.g. the fetal aorta) and venous (e.g. umbilical vein, inferior vena cava) vessels is currently only recommended if it is carried out as part of a study, as the evidence for its usefulness is still insufficient. References: [62] Consensus-based Recommendation 5.E27
When planning the time of delivery, the risks associated with preterm birth must be weighed up against the risks of remaining in the womb.
References: [118] Consensus-based Statement 5.S10
Age of gestation is a significant factor affecting survival without morbidity.
References: [3, 72, 119, 120] Consensus-based Recommendation 5.E28
If CTG pathologies such as recurrent decelerations resistant to treatment occur, delivery of the infant must be considered at all times.
References: [100] Consensus-based Recommendation 5.E29
Expert consensus Level of consensus +++ Delivery of the infant must be considered if short-term variation (STV) < 2.6 ms occurs between GW 26 + 0 and GW 28 + 6 or a STV < 3 ms occurs between GW 29 + 0 and GW 32 + 0.
References: [100] 
Consensus-based Recommendation 5.E33
Expert consensus Level of consensus +++ If Doppler sonography of the umbilical artery reveals absent end-diastolic flow (AEDF), the infant should be delivered by GW 34 + 0 at the latest.
Consensus-based Recommendation 5.E34
Expert consensus Level of consensus +++ If Doppler sonography of the umbilical artery reveals increased pulsatility (PI > 95th percentile), the aim should be to deliver the infant from GW 37 + 0.
References: [123] Consensus-based Recommendation 5.E35
Expert consensus Level of consensus ++
If Doppler sonography of the middle cerebral artery reveals decreased pulsatility (PI < 5th percentile), delivery of the infant by GW 37 + 0 at the latest should be considered.
Consensus-based Recommendation 5.E36
Expert consensus Level of consensus +++ If the CPR (cerebroplacental ratio) is low, the aim from GW 37 + 0 should be to deliver the infant.
References: [61, 77 -80] 
5.4.3
Type of delivery
Additional recommendations
Outpatient or inpatient monitoring and care
Bed rest
There is very little evidence-based data on hospitalization with bed rest when there is a suspicion of fetal growth restriction, and the data have not shown any benefit [134] .
Diet
Changes in diet, dietary measures or additional intake of food supplements (e.g. calcium [135] ) have not shown any benefit [136] and are therefore not recommended.
Cessation of nicotine use Progesterone
Progesterone has shown no benefit in reducing IUGR [138] and should therefore not be administered for that purpose.
Maternal oxygen administration
The studies on the benefits of maternal oxygen administration are insufficient and some have methodological flaws. These studies were evaluated in an older Cochrane analysis which drew the conclusion that the existing evidence is insufficient to assess the benefits and risk of maternal oxygen administration [139] ; maternal oxygen should therefore not be administered.
Other interventions
Numerous interventions which aim to improve blood flow to the placenta have been studied [140] . But neither the increase in plasma volume [141] nor the administration of low-dose ASA [142] or sildenafil [143, 144] showed any benefit, and they are therefore not recommended. Antihypertensive therapy of pregnant women with hypertensive disease does not improve fetal growth [145, 146] and should not be recommended and neither should the administration of NO donors or vasodilator substances as they have not been sufficiently investigated yet [147] .
6
Information and counseling
The pregnant woman or parents-to-be should receive detailed information and extensive counseling sessions about IUGR as a complication of pregnancy and the individual course and consequences of IUGR. The mother/parents-to-be should also be told that the infant could be constitutionally small, which does not inevitably lead to increased perinatal morbidity. These talks should be given by an interdisciplinary team which includes a specialist for prenatal medicine/obstetrician and neonatologist. Depending on the fetal clinical picture, additional pediatric specialists or specialists for human genetics should also be consulted. In addition to information about the possible causes, information should also be provided about the short-term and long-term consequences, the risk of recurrence and, depending on the case, the possible diagnostic investigations. The individual medical, psychological and social questions of the pregnant woman or the parents-to-be about the diagnosis must then be discussed during a comprehensive medical consultation. All necessary decisions should be taken as part of a joint decision-making process. The most important results of the information and counseling sessions should be documented transparently (see also the S2k-guideline "Preterm infants born at the limits of viability", currently only available in German: "Frühgeborene an der Grenze der Lebensfähigkeit" (196)).
Consensus-based Recommendation 5.E37 Expert consensus
Level of consensus +++
In the case of an isolated SGA (normal Doppler results, no additional risks), delivery may be considered from GW 38 + 0.
References: [124 -126] Consensus-based Recommendation 5.E38
In the case of an isolated SGA (normal Doppler results, no additional risks), the due date must not be exceeded.
Consensus-based Recommendation 5.E39
Expert consensus Level of consensus +++ Not every pregnant woman with IUGR must be delivered by C-section.
Consensus-based Recommendation 5.E40
In the case of IUGR with normal Doppler results or increased pulsatility in the umbilical artery (> 95th percentile), labor may be induced with the goal of vaginal delivery but not if ARED flow is present. However the higher risk of complications must be taken into account and continuous intrapartum monitoring is required.
References: [127 -133] Consensus-based Recommendation 5.E41
Expert consensus Level of consensus +++
The decision for either outpatient or inpatient monitoring and care of the pregnant woman with IUGR must be taken on an individual basis.
Consensus-based Recommendation 5.E42
Expert consensus Level of consensus +++ Cessation of nicotine use must be recommended to all pregnant women.
References: [137] Additional psychological or pastoral care, ideally initiated before the birth, can be an important aspect for parents-to-be [148] .
Prophylaxis
Particularly after a previous IUGR pregnancy, the aim must be to prevent a recurrence of IUGR. Numerous approaches have been used in the past, but only a few of them offer an evidence-based benefit.
Acetylsalicylic acid (ASA)
Antihypertensive therapy 
Sonography
The basic prerequisite for effective screening is accurate data collection (Chapter 3.2.1. Crown-rump length). In addition, it is suggested that, similar to pre-eclampsia screening in the 1st trimester of pregnancy, an attempt could be made to screen for SGA/IUGR using a combination of different markers (maternal medical history, Doppler sonography of the uterine arteries, middle arterial pressure, NT and the maternal serum markers PAPP-A, free β-hCG, PlGF, PP13, and ADAM 12). General screening is not currently recommended yet.
Doppler sonography
Consensus-based Recommendation 7.E43
Expert consensus
Level of consensus +++ If there is a risk of uteroplacental malperfusion and a risk of IUGR, prophylactic intake of low-dose ASA should be started at ≤ 16 GW.
References: [149 -151] Consensus-based Recommendation 7.E44
Expert consensus Level of consensus +++ Special forms of nutrition or food supplements have not been shown to offer an evidence-based benefit and should therefore not be recommended as prophylaxis against IUGR.
References: [135, 153 -158] Consensus-based Statement 7.S11
Expert consensus Level of consensus +++
The administration of low-molecular-weight heparin appears to be a promising prophylactic approach in IUGR. Nevertheless, the currently available evidence is not sufficient for it to be recommended, particularly as there is insufficient evidence concerning possible severe side-effects.
References: [159 -161] Consensus-based Recommendation 7.E45
Expert consensus Level of consensus +++ All pregnant women who smoke must be informed that abstaining from nicotine can reduce the risk of IUGR.
References: [162, 163] Consensus-based recommendation 8.E46
Expert consensus Level of consensus +++ Abnormal Doppler results for the uterine arteries in the form of increased pulsatility (PI > 95th percentile) should be a signal to start regular sonographic monitoring of fetal growth and Doppler sonography of the umbilical artery.
References: [167, 168] 
